BRT-logo-final.png
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 09, 2021 11:58 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
Logo 1.jpg
Verano to Open 32nd MÜV™ Florida Medical Cannabis Dispensary in Historic St. Augustine
April 23, 2021 07:00 ET | Verano Holdings Corp.
Verano secures the fourth largest retail footprint in Florida. St. Augustine is the fifth MÜV™ location with a drive-through to offer patients a convenient method of order pickup. CHICAGO,...
logo.png
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
April 04, 2019 09:15 ET | Adhera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and...
Logo.png
INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimer’s Disease
February 11, 2019 08:00 ET | INmune Bio, Inc.
The Alzheimer’s Association awarded INmune Bio the Part the Cloud to RESCUE grant to target neuroinflammation in Alzheimer’s Disease LA JOLLA, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- INmune...
Logo.jpg
Endonovo Expands SofPulse Commercialization
December 13, 2018 09:20 ET | Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Logo.png
IMAC Holdings, Inc. Announces Research Scientist, Dr. Ian White, Joins IMAC Regeneration Centers As Chief Scientific Officer
September 13, 2018 15:16 ET | IMAC Holdings, Inc.
Brentwood, TN, Sept. 13, 2018 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC”), a provider of regenerative rehabilitation orthopedic medical treatments without the use of surgery or opioids,...
OM_Logo-4c.jpg
Emerging Science Shaping Behavioral Health Service Delivery:The Focus of October mhca National Innovation Incubator
October 11, 2017 07:30 ET | Open Minds
Gettysburg, PA, Oct. 11, 2017 (GLOBE NEWSWIRE) -- mhca will kick off their Fall conference of 2017 at the Westin Kierland Resort in Scottsdale, Arizona. The conference will kick off with a half-day...
Cantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliX
April 12, 2016 12:00 ET | Cantabio Pharmaceuticals Inc.
PALO ALTO, Calif., April 12, 2016 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB:CTBO) announced today a new preclinical therapeutic program for Alzheimer’s Disease which it is...
CANTABio and Gardedam Therapeutics complete Merger to Tackle Development of Novel Therapeutics for Alzheimer's and Parkinson's Disease
December 21, 2015 13:00 ET | Cantabio Pharmaceuticals Inc.
PALO ALTO, Calif., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals, Inc. ("Cantabio") (OTCQB:CTBO) is pleased to announce the completion of its reverse merger (the "Merger") with...
AIMLogo.jpg
Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26
June 25, 2014 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, June 25, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), will present a corporate update on their Advanced Therapies for the Human...